Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017 (2017), Article ID 5625371, 7 pages
https://doi.org/10.1155/2017/5625371
Review Article

A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases

Department of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University and Teaching Hospital of Peking University, 8 Jingshundong Street, Beijing 100015, China

Correspondence should be addressed to Huichun Xing

Received 1 December 2016; Revised 21 January 2017; Accepted 30 January 2017; Published 2 March 2017

Academic Editor: Ruozhi Zhao

Copyright © 2017 Yingying Zhao and Huichun Xing. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. A. Fonseca, M. S. Kirkman, T. Darsow, and R. E. Ratner, “The American Diabetes Association diabetes research perspective,” Diabetes Care, vol. 35, no. 6, pp. 1380–1387, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, “Global estimates of the prevalence of diabetes for 2010 and 2030,” Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. J.-Y. Lee, I. Jeon, J. M. Lee, J.-M. Yoon, and S. M. Park, “Diabetes mellitus as an independent risk factor for lung cancer: a meta-analysis of observational studies,” European Journal of Cancer, vol. 49, no. 10, pp. 2411–2423, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. J. D. Yang, H. A. Mohamed, J. L. Cvinar, G. J. Gores, L. R. Roberts, and W. R. Kim, “Diabetes mellitus heightens the risk of hepatocellular carcinoma except in patients with hepatitis C cirrhosis,” American Journal of Gastroenterology, vol. 11, no. 11, pp. 1573–1580, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. H. L. Reeves, M. Y. W. Zaki, and C. P. Day, “Hepatocellular carcinoma in obesity, type 2 diabetes, and NAFLD,” Digestive Diseases and Sciences, vol. 61, no. 5, pp. 1234–1245, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. D. García-Compeán, J. A. González-González, F. J. Lavalle-González, E. I. González-Moreno, J. Z. Villarreal-Pérez, and H. J. Maldonado-Garza, “Hepatogenous diabetes: is it a neglected condition in chronic liver disease?” World Journal of Gastroenterology, vol. 22, no. 10, pp. 2869–2874, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. D. García-Compeán, J. A. González-González, F. J. Lavalle-González, E. I. González-Moreno, J. Z. Villarreal-Pérez, and H. J. Maldonado-Garza, “Current concepts in diabetes mellitus and chronic liver disease: clinical outcomes, hepatitis C virus association, and therapy,” Digestive Diseases and Sciences, vol. 61, no. 2, pp. 371–380, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Garcia-Compean, J. O. Jacquez-Quintana, J. A. Gonzalez-Gonzalez, and H. Maldonado-Garza, “Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management,” World Journal of Gastroenterology, vol. 15, no. 3, pp. 280–288, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Holstein, S. Hinze, E. Thiessen, A. Plaschke, and E.-H. Egberts, “Clinical implications of hepatogenous diabetes in liver cirrhosis,” Journal of Gastroenterology and Hepatology, vol. 17, no. 6, pp. 677–681, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Lin, H.-Y. Ou, L.-M. Chuang, and K. C. Chiu, “Diabetes prevention through prevention of hepatitis B,” Hepatology, vol. 64, no. 3, pp. 987–988, 2016. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Huang, H.-Y. Ou, J. Lin et al., “The impact of hepatitis B vaccination status on the risk of diabetes, implicating diabetes risk reduction by successful vaccination,” PLoS ONE, vol. 10, no. 10, Article ID e0139730, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Pavone, T. Tieghi, G. d'Ettorre et al., “Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents,” Clinical Microbiology and Infection, vol. 22, no. 5, pp. 462.e1–462.e3, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. N. Custro, A. Carroccio, A. Ganci et al., “Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis,” Diabetes and Metabolism, vol. 27, no. 4 I, pp. 476–481, 2001. View at Google Scholar · View at Scopus
  14. M. Li-Ng, S. Tropp, A. Danoff, and E. J. Bini, “Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders,” Digestive and Liver Disease, vol. 39, no. 6, pp. 549–556, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. Z.-S. Huang, T.-S. Huang, T.-H. Wu, M.-F. Chen, C.-S. Hsu, and J.-H. Kao, “Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten-year observation,” Journal of Gastroenterology and Hepatology, vol. 25, no. 8, pp. 1420–1425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Cai, J. Zeng, H. Wu et al., “Association between hepatitis B virus infection and diabetes mellitus: a meta-analysis,” Experimental and Therapeutic Medicine, vol. 10, no. 2, pp. 693–698, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. T. T. Lao, K.-Y. Tse, L. Y. Chan, K.-F. Tam, and L.-F. Ho, “HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women,” Diabetes Care, vol. 26, no. 11, pp. 3011–3016, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. C. H. Guo, T. T. Sun, X. D. Weng et al., “The investigation of glucose metabolism and insulin secretion in subjects of chronic hepatitis B with cirrhosis,” International Journal of Clinical and Experimental Pathology, vol. 8, no. 10, pp. 13381–13386, 2015. View at Google Scholar
  19. Y. Shen, J. Zhang, H. Cai et al., “Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls,” BMC Gastroenterology, vol. 15, article 32, pp. 1–8, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. G. V. Papatheodoridis, N. Chrysanthos, S. Savvas et al., “Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis,” Journal of Viral Hepatitis, vol. 13, no. 5, pp. 303–310, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Qureshi, T. Ahsan, S. A. Mujeeb et al., “Diabetes mellitus is equally frequent in chronic HCV and HBV infection,” The Journal of the Pakistan Medical Association, vol. 52, no. 7, pp. 280–283, 2002. View at Google Scholar · View at Scopus
  22. D. Peng, Y. Han, H. Ding, and L. Wei, “Hepatic steatosis in chronic hepatitis B patients is associated with metabolic factors more than viral factors,” Journal of Gastroenterology and Hepatology, vol. 23, no. 7, pp. 1082–1088, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. W. Yun, Y. K. Cho, J. H. Park et al., “Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B,” Liver International, vol. 29, no. 6, pp. 878–883, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. C.-C. Wang, C.-S. Hsu, C.-J. Liu, J.-H. Kao, and D.-S. Chen, “Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis,” Journal of Gastroenterology and Hepatology (Australia), vol. 23, no. 5, pp. 779–782, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. Y.-W. Huang, T.-C. Wang, S.-C. Lin et al., “Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study,” Clinical Infectious Diseases, vol. 57, no. 12, pp. 1695–1702, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Raddatz and G. Ramadori, “Carbohydrate metabolism and the liver: actual aspects from physiology and disease,” Zeitschrift für Gastroenterologie, vol. 45, no. 1, pp. 51–62, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Teli, D. Xanthaki, and K. P. Karalis, “Regulation of appetite and insulin signaling in inflammatory states,” Annals of the New York Academy of Sciences, vol. 1083, pp. 319–328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Collier, L. A. Dossett, A. K. May, and J. J. Diaz, “Glucose control and the inflammatory response,” Nutrition in Clinical Practice, vol. 23, no. 1, pp. 3–15, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. I. A. Leclercq, A. Da Silva Morais, B. Schroyen, N. Van Hul, and A. Geerts, “Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences,” Journal of Hepatology, vol. 47, no. 1, pp. 142–156, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. C. H. Guo, T. T. Sun, X. D. Weng et al., “The investigation of glucose metabolism and insulin secretion in subjects of chronic hepatitis B with cirrhosis,” International Journal of Clinical & Experimental Pathology, vol. 8, no. 10, pp. 13381–13386, 2015. View at Google Scholar
  31. S. Majumder, B. Bockorny, W. L. Baker, and C. A. Dasanu, “Association between HBsAg positivity and pancreatic cancer: a meta-analysis,” Journal of gastrointestinal cancer, vol. 45, no. 3, pp. 347–352, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Zhang, Y. Shen, H. Cai, Y.-M. Liu, and G. Qin, “Hepatitis B virus infection status and risk of type 2 diabetes mellitus: a meta-analysis,” Hepatology Research, vol. 45, no. 11, pp. 1100–1109, 2016. View at Publisher · View at Google Scholar · View at Scopus
  33. D. Ji, J. Cheng, J. Dong, Y. Liu, J.-J. Wang, and J. Guo, “Screening and identification of genes trans-regulated by HBV pre-S2 protein with cDNA microarray,” World Chinese Journal of Digestology, vol. 12, no. 7, pp. 1559–1563, 2004. View at Google Scholar · View at Scopus
  34. M. E. D. Allison, T. Wreghitt, C. R. Palmer, and G. J. M. Alexander, “Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population,” Journal of Hepatology, vol. 21, no. 6, pp. 1135–1139, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Cacoub, C. Comarmond, F. Domont, L. Savey, A. C. Desbois, and D. Saadoun, “Extrahepatic manifestations of chronic hepatitis C virus infection,” Therapeutic Advances in Infectious Disease, vol. 3, no. 1, pp. 3–14, 2016. View at Publisher · View at Google Scholar
  36. R. J. Wong and R. G. Gish, “Metabolic manifestations and complications associated with chronic hepatitis C virus infection,” Gastroenterology & Hepatology, vol. 12, no. 5, pp. 293–299, 2016. View at Google Scholar · View at Scopus
  37. L. E. Adinolfi, L. Restivo, R. Zampino, A. Lonardo, and P. Loria, “Metabolic alterations and chronic hepatitis C: treatment strategies,” Expert Opinion on Pharmacotherapy, vol. 12, no. 14, pp. 2215–2234, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Lonardo, L. E. Adinolfi, L. Restivo et al., “Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen,” World Journal of Gastroenterology, vol. 20, no. 23, pp. 7089–7103, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. A. J. van der Meer and M. Berenguer, “Reversion of disease manifestations after HCV eradication,” Journal of Hepatology, vol. 65, no. 1, pp. S95–S108, 2016. View at Publisher · View at Google Scholar
  40. E. Vanni, E. Bugianesi, and G. Saracco, “Treatment of type 2 diabetes mellitus by viral eradication in chronic hepatitis C: Myth or reality?” Digestive and Liver Disease, vol. 48, no. 2, pp. 105–111, 2016. View at Publisher · View at Google Scholar · View at Scopus
  41. M. L. Shiffman and Y. Benhamou, “Cure of HCV related liver disease,” Liver International, vol. 35, no. 1, pp. 71–77, 2015. View at Publisher · View at Google Scholar · View at Scopus
  42. E. G. Meissner, Y.-J. Lee, A. Osinusi et al., “Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients,” Hepatology, vol. 61, no. 3, pp. 790–801, 2015. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Eslam, M. A. Khattab, and S. A. Harrison, “Insulin resistance and hepatitis C: an evolving story,” Gut, vol. 60, no. 8, pp. 1139–1151, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. E. I. Elhawary, G. F. Mahmoud, M. A. El-Daly, F. A. Mekky, G. G. Esmat, and M. Abdel-Hamid, “Association of HCV with diabetes mellitus: an Egyptian case-control study,” Virology Journal, vol. 8, article 367, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. M. S. Memon, Z. I. Arain, F. Naz, M. Zaki, S. Kumar, and A. A. Burney, “Prevalence of type 2 diabetes mellitus in hepatitis c virus infected population: A Southeast Asian study,” Journal of Diabetes Research, vol. 2013, Article ID 539361, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Ratziu, A. Heurtier, L. Bonyhay, T. Poynard, and P. Giral, “Review article: an unexpected virus-host interaction—the hepatitis C virus-diabetes link,” Alimentary Pharmacology and Therapeutics, vol. 22, no. 2, pp. 56–60, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. S. S. Hammerstad, S. F. Grock, H. J. Lee, A. Hasham, N. Sundaram, and Y. Tomer, “Diabetes and hepatitis C: a two-way association,” Frontiers in Endocrinology, vol. 6, article 134, 2015. View at Publisher · View at Google Scholar
  48. T. Zornitzki, S. Malnick, L. Lysyy, and H. Knobler, “Interferon therapy in hepatitis C leading to chronic type 1 diabetes,” World Journal of Gastroenterology, vol. 21, no. 1, pp. 233–239, 2015. View at Publisher · View at Google Scholar · View at Scopus
  49. C. E. Ruhl, A. Menke, C. C. Cowie, and J. E. Everhart, “Relationship of hepatitis C virus infection with diabetes in the U.S. population,” Hepatology, vol. 60, no. 4, pp. 1139–1149, 2014. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Simó, A. Lecube, J. Genescà, J. I. Esteban, and C. Hernández, “Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection,” Diabetes Care, vol. 29, no. 11, pp. 2462–2466, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Romero-Gómez, C. M. Fernández-Rodríguez, R. J. Andrade et al., “Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C,” Journal of Hepatology, vol. 48, no. 5, pp. 721–727, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Knobler and S. Malnick, “Hepatitis C and insulin action: an intimate relationship,” World Journal of Hepatology, vol. 8, no. 2, pp. 131–138, 2016. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Arase, F. Suzuki, Y. Suzuki et al., “Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C,” Hepatology, vol. 49, no. 3, pp. 739–744, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. F. Imazeki, O. Yokosuka, K. Fukai, T. Kanda, H. Kojima, and H. Saisho, “Prevalence of diabetes mellitus and insulin resistance in patients with chronic hepatitis C: comparison with hepatitis B virus-infected and hepatitis C virus-cleared patients,” Liver International, vol. 28, no. 3, pp. 355–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. C.-S. Wang, S.-T. Wang, W.-J. Yao, T.-T. Chang, and P. Chou, “Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study,” American Journal of Epidemiology, vol. 166, no. 2, pp. 196–203, 2007. View at Publisher · View at Google Scholar · View at Scopus
  56. J.-F. Huang, C.-Y. Dai, S.-J. Hwang et al., “Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication,” American Journal of Gastroenterology, vol. 102, no. 6, pp. 1237–1243, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. D. Kralj, L. Virović Jukić, S. Stojsavljević et al., “Hepatitis C virus, insulin resistance, and steatosis,” Journal of Clinical and Translational Hepatology, vol. 4, no. 1, pp. 66–75, 2016. View at Publisher · View at Google Scholar
  58. F. Negro, “Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases,” Journal of Hepatology, vol. 61, no. 1, pp. S69–S78, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. J. P. Arab, F. Barrera, C. Gallego et al., “High prevalence of undiagnosed liver cirrhosis and advanced fibrosis in type 2 diabetic patients,” Annals of Hepatology, vol. 15, no. 5, pp. 721–728, 2016. View at Publisher · View at Google Scholar · View at Scopus
  60. D. García-Compeán, J. A. González-González, F. J. Lavalle-González, E. I. González-Moreno, H. J. Maldonado-Garza, and J. Z. Villarreal-Pérez, “The treatment of diabetes mellitus of patients with chronic liver disease,” Annals of Hepatology, vol. 14, no. 6, pp. 780–788, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. L. Elkrief, P. Chouinard, N. Bendersky et al., “Diabetes mellitus is an independent prognostic factor for major liver-related outcomes in patients with cirrhosis and chronic hepatitis C,” Hepatology, vol. 60, no. 3, pp. 823–831, 2014. View at Publisher · View at Google Scholar · View at Scopus
  62. I. Sporea, R. Mare, R. Lupuşoru et al., “Liver stiffness evaluation by transient elastography in type 2 diabetes mellitus patients with ultrasound-proven steatosis,” Journal of Gastrointestinal and Liver Diseases, vol. 25, no. 2, pp. 167–174, 2016. View at Google Scholar · View at Scopus
  63. P. Jepsen, H. Watson, P. K. Andersen, and H. Vilstrup, “Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients,” Journal of Hepatology, vol. 63, no. 5, pp. 1133–1138, 2015. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Elkrief, P.-E. Rautou, S. Sarin, D. Valla, V. Paradis, and R. Moreau, “Diabetes mellitus in patients with cirrhosis: clinical implications and management,” Liver International, vol. 36, no. 7, pp. 936–948, 2016. View at Publisher · View at Google Scholar · View at Scopus
  65. T. Kimura, A. Kobayashi, N. Tanaka et al., “Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection,” Hepatology Research, vol. 28, no. 10, pp. 2344–2352, 2011. View at Google Scholar
  66. W. K. Si, J. W. Chung, J. Cho et al., “Predictors of increased risk of hepatocellular carcinoma in patients with type 2 diabetes,” PLOS ONE, vol. 11, no. 6, Article ID e0158066, 2016. View at Publisher · View at Google Scholar
  67. C.-H. Hung, C.-M. Lee, J.-H. Wang et al., “Impact of diabetes mellitus on incidence of hepatocellular carcinoma in chronic hepatitis C patients treated with interferon-based antiviral therapy,” International Journal of Cancer, vol. 128, no. 10, pp. 2344–2352, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Hedenstierna, A. Nangarhari, O. Weiland, and S. Aleman, “Diabetes and cirrhosis are risk factors for hepatocellular carcinoma after successful treatment of chronic hepatitis C,” Clinical Infectious Diseases, vol. 63, no. 6, pp. 723–729, 2016. View at Publisher · View at Google Scholar
  69. H. L. Reeves, M. Y. W. Zaki, and C. P. Day, “Hepatocellular carcinoma in obesity, Type 2 diabetes, and NAFLD,” Digestive Diseases and Sciences, vol. 61, no. 5, pp. 1234–1245, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. K. Shikata, T. Ninomiya, and Y. Kiyohara, “Diabetes mellitus and cancer risk: review of the epidemiological evidence,” Cancer Science, vol. 104, no. 1, pp. 9–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  71. K. Fujita, H. Iwama, H. Miyoshi et al., “Diabetes mellitus and metformin in hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 22, no. 27, pp. 6100–6113, 2016. View at Publisher · View at Google Scholar · View at Scopus
  72. A. Forner, J. M. Llovet, and J. Bruix, “Hepatocellular carcinoma,” The Lancet, vol. 379, no. 9822, pp. 1245–1255, 2012. View at Publisher · View at Google Scholar · View at Scopus
  73. F. Capone, E. Guerriero, G. Colonna et al., “The cytokinome profile in patients with hepatocellular carcinoma and type 2 diabetes,” PLoS ONE, vol. 10, no. 7, Article ID e0134594, 2015. View at Publisher · View at Google Scholar · View at Scopus
  74. M. Jiménez-Pérez, R. González-Grande, E. O. Guzmán, V. A. Trillo, and J. M. R. López, “Metabolic complications in liver transplant recipients,” World Journal of Gastroenterology, vol. 22, no. 28, pp. 6416–6423, 2016. View at Publisher · View at Google Scholar · View at Scopus
  75. F.-C. Liu, J.-R. Lin, H.-P. Chen, Y.-F. Tsai, and H.-P. Yu, “Prevalence, predictive factors, and survival outcome of new-onset diabetes after liver transplantation: a population-based cohort study,” Medicine, vol. 95, no. 25, Article ID e3829, 2016. View at Publisher · View at Google Scholar · View at Scopus
  76. Q. Ling, X. Xu, B. Wang, L. Li, and S. Zheng, “The origin of new-onset diabetes after liver transplantation: liver, islets, or gut?” Transplantation, vol. 100, no. 4, pp. 808–813, 2016. View at Publisher · View at Google Scholar · View at Scopus
  77. J. Zheng and W.-L. Wang, “Risk factors of metabolic syndrome after liver transplantation,” Hepatobiliary & Pancreatic Diseases International, vol. 14, no. 6, pp. 582–587, 2015. View at Publisher · View at Google Scholar · View at Scopus